| Product Code: ETC7243636 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2023, Gabon continued to rely on top exporters such as France, USA, Argentina, Italy, and Denmark for large molecule drug substance CDMO import shipments. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, while the impressive Compound Annual Growth Rate (CAGR) of 35.73% and growth rate of 28.28% highlight a thriving industry with significant potential for continued expansion. Gabon`s consistent import of these substances from diverse global sources underscores the country`s commitment to meeting the healthcare needs of its population through international partnerships.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Gabon Large Molecule Drug Substance CDMO Market Overview |
3.1 Gabon Country Macro Economic Indicators |
3.2 Gabon Large Molecule Drug Substance CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Gabon Large Molecule Drug Substance CDMO Market - Industry Life Cycle |
3.4 Gabon Large Molecule Drug Substance CDMO Market - Porter's Five Forces |
3.5 Gabon Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 Gabon Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 Gabon Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Gabon Large Molecule Drug Substance CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for large molecule drug substances outsourcing services due to complexity and cost-effectiveness. |
4.2.2 Technological advancements in biopharmaceutical manufacturing processes driving the need for specialized CDMO services. |
4.2.3 Growing trend of pharmaceutical companies focusing on core competencies and outsourcing non-core activities like drug substance manufacturing. |
4.3 Market Restraints |
4.3.1 Regulatory challenges and compliance requirements in the pharmaceutical industry impacting the outsourcing of drug substance manufacturing. |
4.3.2 High initial investment costs for setting up large molecule drug substance manufacturing facilities. |
4.3.3 Intellectual property concerns and confidentiality issues in outsourcing drug substance production to CDMOs. |
5 Gabon Large Molecule Drug Substance CDMO Market Trends |
6 Gabon Large Molecule Drug Substance CDMO Market, By Types |
6.1 Gabon Large Molecule Drug Substance CDMO Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 Gabon Large Molecule Drug Substance CDMO Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 Gabon Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Manufacturing, 2021- 2031F |
6.1.4 Gabon Large Molecule Drug Substance CDMO Market Revenues & Volume, By Clinical, 2021- 2031F |
6.1.5 Gabon Large Molecule Drug Substance CDMO Market Revenues & Volume, By Commercial, 2021- 2031F |
6.1.6 Gabon Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Development, 2021- 2031F |
6.1.7 Gabon Large Molecule Drug Substance CDMO Market Revenues & Volume, By Cell Line Development, 2021- 2031F |
6.1.8 Gabon Large Molecule Drug Substance CDMO Market Revenues & Volume, By Process Development, 2021- 2031F |
6.2 Gabon Large Molecule Drug Substance CDMO Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 Gabon Large Molecule Drug Substance CDMO Market Revenues & Volume, By Mammalian, 2021- 2031F |
6.2.3 Gabon Large Molecule Drug Substance CDMO Market Revenues & Volume, By Microbial, 2021- 2031F |
6.2.4 Gabon Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Gabon Large Molecule Drug Substance CDMO Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Gabon Large Molecule Drug Substance CDMO Market Revenues & Volume, By Biotech Companies, 2021- 2031F |
6.3.3 Gabon Large Molecule Drug Substance CDMO Market Revenues & Volume, By CRO, 2021- 2031F |
6.3.4 Gabon Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 Gabon Large Molecule Drug Substance CDMO Market Import-Export Trade Statistics |
7.1 Gabon Large Molecule Drug Substance CDMO Market Export to Major Countries |
7.2 Gabon Large Molecule Drug Substance CDMO Market Imports from Major Countries |
8 Gabon Large Molecule Drug Substance CDMO Market Key Performance Indicators |
8.1 Capacity utilization rate of gabon large molecule drug substance CDMOs. |
8.2 Number of partnerships and collaborations with pharmaceutical companies. |
8.3 Rate of successful technology transfers and scale-up processes. |
8.4 Turnaround time for manufacturing large molecule drug substances. |
8.5 Number of new product introductions and successful commercializations. |
9 Gabon Large Molecule Drug Substance CDMO Market - Opportunity Assessment |
9.1 Gabon Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 Gabon Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 Gabon Large Molecule Drug Substance CDMO Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Gabon Large Molecule Drug Substance CDMO Market - Competitive Landscape |
10.1 Gabon Large Molecule Drug Substance CDMO Market Revenue Share, By Companies, 2024 |
10.2 Gabon Large Molecule Drug Substance CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |